BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36034802)

  • 1. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
    Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
    Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency.
    Xia W; Wang T; Pan JY
    World J Clin Cases; 2023 Oct; 11(28):6715-6724. PubMed ID: 37901029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study.
    Qiao Y; Wang Z; Han J; Li G
    Int J Endocrinol; 2019; 2019():1438723. PubMed ID: 31641350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.
    Witkowska-Sędek E; Labochka D; Majcher A; Pyrżak B
    Cent Eur J Immunol; 2018; 43(1):69-75. PubMed ID: 29736148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Tsurayya G; Nazhifah CA; Pirwanja MR; Zulfa PO; Tatroman MRR; Fakri F; Iqhrammullah M
    Children (Basel); 2024 Feb; 11(2):. PubMed ID: 38397339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial.
    Zaeri H; Omidvar S; Servatian N; Arefnia S; Khademolreza N; Amini H; Taghavi B; Hashemipour M; Eshraghi P; Ghasemi M; Ghergherehchi R; Maleki E; Moravej H; Noorian S; Soheilipour F; Dalili S; Kharazmi H; Didban A; Akhlaghi A; Ghaznavi S; Shahbazi M
    Expert Opin Drug Saf; 2024 May; ():1-9. PubMed ID: 38682328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone Treatment in Children with Perthes Disease and Growth Hormone Deficiency: A Case Report and Literature Review.
    Shi Y; Ying Y; Luo X; Hou L
    Endocr Metab Immune Disord Drug Targets; 2023; 23(13):1668-1673. PubMed ID: 37150982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
    Lin Z; Shu AD; Bach M; Miller BS; Rogol AD
    J Endocr Soc; 2022 Jan; 6(1):bvab168. PubMed ID: 34913019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and patient satisfaction of norditropin and sogroya in patients with growth hormone deficiency: a systematic review and meta-analysis of randomized controlled trials.
    Altobaishat O; Abouzid M; Moawad MHED; Sharaf A; Al-Ajlouni Y; Umar TP; Bani-Salameh A; Tanashat M; Bataineh OA; Nashwan AJ
    Endocrine; 2024 Apr; ():. PubMed ID: 38658475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of A Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone (rhGH) Therapy Use in Children with Growth Hormone Deficiency (GHD) - A GloBE-Reg Initiative.
    Chen SC; Bryce J; Chen M; Charmandari E; Choi JH; Dou X; Gong C; Hamza R; Harvey J; Hoffman AR; Horikawa R; Johannson G; Jorge AAL; Miller BS; Roehrich S; Sävendahl L; Tseretopoulou X; Vitali D; Wajnrajch M; Ahmed SF
    Horm Res Paediatr; 2023 Sep; ():. PubMed ID: 37703843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone Treatment in Children of Normal Height.
    Mendonca BB; Arnhold IJP
    J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38958114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9804819. PubMed ID: 37387982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-acting polyethylene glycol recombinant human growth hormone dosages in pediatric practice: A pooled analysis of two phase IV randomized controlled trials.
    Hou L; Chen X; Du H; Zhang J; Cheng X; Pan J; Pan H; Liao W; Luo X; Fu J;
    Chin Med J (Engl); 2024 Feb; ():. PubMed ID: 38420845
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting PEGylated growth hormone in children with idiopathic short stature.
    Luo X; Zhao S; Yang Y; Dong G; Chen L; Li P; Luo F; Gong C; Xu Z; Xu X; Gong H; Du H; Hou L; Zhong Y; Shi Q; Chen X; Chen X; Xu L; Cheng R; Su C; Ma Y; Xu L; Zhang L; Lu H
    Eur J Endocrinol; 2022 Nov; 187(5):709-718. PubMed ID: 36130048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study.
    Hou L; Huang K; Gong C; Luo F; Wei H; Liang L; Du H; Zhang J; Zhong Y; Chen R; Chen X; Pan J; Jin X; Zeng T; Liao W; Liu D; Lan D; Zhu S; Dong Z; Ma H; Yang Y; Xiong F; Lu P; Cheng S; Gu X; Jin R; Liu Y; Wu J; Xu X; Chen L; Dong Q; Pan H; Su Z; Liu L; Luo X; Ni S; Chen Z; Hu Y; Wang C; Liu J; Liu L; Lu B; Wang X; Wang Y; Yang F; Zhang M; Cao L; Liu G; Yao H; Zhan Y; Dai M; Li G; Li L; Liu Y; Wang K; Xiao Y; Zhang X; Dong J; Gu Z; Ying L; Huang F; Liu Y; Liu Z; Ye J; Zhao D; Hu X; Jiang Z; Ye K; Zhu H; Chen S; Chen X; Wan N; Xu Z; Yin Q; Zhang H; Huang X; Yin J; Zhang H; Li P; Yin P; Fu J; Luo X
    J Clin Endocrinol Metab; 2023 Jul; 108(8):2078-2086. PubMed ID: 36669772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study.
    Jiang Z; Chen X; Dong G; Lou Y; Zhang J; Cheng X; Pan J; Liao W; Wu J; Huang X; Jin X; Liu D; Zeng T; Zhu S; Dong Q; Luo X; Lan D; Cao L; Zhang X; Liu J; Dai M; Zhang M; Liu L; Dong J; Zhao D; Ni S; Fu J
    Front Pharmacol; 2022; 13():955809. PubMed ID: 36034802
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.